Efficacy and safety of MYL-1501D vs insulin glargine in patients with type 1 diabetes after 52 weeks: Results of the INSTRIDE 1 phase III study

Diabetes Obesity and Metabolism ◽

10.1111/dom.13322 ◽

2018 ◽

Vol 20 (8) ◽

pp. 1944-1950 ◽

Author(s):

Thomas C. Blevins ◽

Abhijit Barve ◽

Bin Sun ◽

Michael Ankersen

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Phase Iii ◽

Efficacy And Safety ◽

Phase Iii Study

Download Full-text

Long‐term (52‐week) efficacy and safety of ipragliflozin add‐on therapy to insulin in Japanese patients with type 1 diabetes mellitus: An uncontrolled, open‐label extension of a phase III study

Journal of Diabetes Investigation ◽

10.1111/jdi.13181 ◽

2020 ◽

Vol 11 (3) ◽

pp. 662-671

Author(s):

Kohei Kaku ◽

Hiroyuki Isaka ◽

Taishi Sakatani ◽

Junko Toyoshima

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Japanese Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label Extension ◽

Phase Iii Study

Download Full-text

Comparable efficacy and safety between LY2963016 insulin glargine and insulin glargine (Lantus®) in Chinese patients with type 1 diabetes: a phase III , randomized, controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14463 ◽

2021 ◽

Author(s):

Xiang Yan ◽

Shan Jiang ◽

Ying Lou ◽

Zhiguang Zhou

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Phase Iii ◽

Chinese Patients ◽

Comparable Efficacy ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text

A randomized crossover study of the efficacy and safety of switching from insulin glargine to insulin degludec in children with type 1 diabetes

Endocrine Journal ◽

10.1507/endocrj.ej16-0294 ◽

2017 ◽

Vol 64 (2) ◽

pp. 133-140 ◽

Author(s):

Tatsuhiko Urakami ◽

Yusuke Mine ◽

Masako Aoki ◽

Misako Okuno ◽

Junichi Suzuki

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Crossover Study ◽

Insulin Degludec ◽

Efficacy And Safety ◽

Randomized Crossover Study

Download Full-text

729-P: Efficacy and Safety of Mylan Insulin Glargine Products (MYL-1501D) from Two Manufacturing Processes (Process V and Process VI) in Combination with Insulin Lispro in Subjects with Type 1 Diabetes Mellitus

Diabetes ◽

10.2337/db21-729-p ◽

2021 ◽

Vol 70 (Supplement 1) ◽

pp. 729-P

Author(s):

YARON RAITER ◽

THOMAS BLEVINS ◽

BIN SUN ◽

ANOOP CHULLIKANA ◽

GOPINATH RANGANNA ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Insulin Lispro ◽

Manufacturing Processes ◽

Efficacy And Safety

Download Full-text

Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes

Diabetes Care ◽

10.2337/dc13-0327 ◽

2014 ◽

Vol 37 (10) ◽

pp. 2746-2754 ◽

Author(s):

Ronnie Aronson ◽

Peter A. Gottlieb ◽

Jens S. Christiansen ◽

Thomas W. Donner ◽

Emanuele Bosi ◽

...

Keyword(s):

Monoclonal Antibody ◽

Type 1 Diabetes ◽

Low Dose ◽

Phase Iii ◽

Recent Onset ◽

Study Results ◽

Phase Iii Study ◽

Human Type 1 Diabetes

Download Full-text

Review for "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in Patients With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study"

10.1111/dom.13904/v1/review1 ◽

2019 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Efficacy And Safety ◽

Phase 3 ◽

Download Full-text

Review for "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in Patients With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study"

10.1111/dom.13904/v1/review3 ◽

2019 ◽

Author(s):

Linsey Gani

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Efficacy And Safety ◽

Phase 3 ◽

Download Full-text

A randomized crossover study of the efficacy and safety of switching from insulin glargine to insulin degludec among patients with type 1 diabetes

Diabetology International ◽

10.1007/s13340-013-0154-7 ◽

2014 ◽

Vol 5 (1) ◽

pp. 74-77 ◽

Author(s):

Kentaro Yamada ◽

Hitomi Nakayama ◽

Shuichi Sato ◽

Yuji Tajiri ◽

Hiroh Kaku ◽

...

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Crossover Study ◽

Insulin Degludec ◽

Efficacy And Safety ◽

Randomized Crossover Study

Download Full-text

Author response for "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in Patients With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study"

10.1111/dom.13904/v2/response1 ◽

2019 ◽

Author(s):

Thomas C. Blevins ◽

Abhijit Barve ◽

Yaron Raiter ◽

Patrick Aubonnet ◽

Sandeep Athalye ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Author Response ◽

Efficacy And Safety ◽

Phase 3 ◽

Download Full-text

Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13922 ◽

2019 ◽

Vol 22 (4) ◽

pp. 540-548 ◽

Author(s):

Eiichi Araki ◽

Hirotaka Watada ◽

Yasuko Uchigata ◽

Osamu Tomonaga ◽

Hitomi Fujii ◽

...

Keyword(s):

Clinical Trial ◽

Type 1 Diabetes ◽

Japanese Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Phase Iii Clinical Trial ◽

Open Label Phase

Download Full-text